Clinical trials
Risk Stratification clinical trials
Below are recruiting risk stratification clinical trials, each written for real people, not researchers. We’re tracking 65 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05442970Recruiting
Study to assess risk of atrial fibrillation
This study looks at how to better judge a person’s risk of developing atrial fibrillation, a type of irregular heartbeat. You may help researchers by completing interviews and assessments that guide future risk estimates.
HamburgAges 18–85 - NCT05472207Recruiting
Risk check study for heart disease patients
This study looks at how to better sort people with heart disease into different risk groups. You may be asked for information about your heart condition and related health to help guide future care.
Innsbruck, TyrolAges 18 years+ - NCT05665504Recruiting
Biomarker test for managing early lung nodules after treatment
This study looks at lung “biomarkers” (test results from your nodule/tissue) to better predict risk of cancer coming back and to guide long-term follow-up. It may help doctors choose the best surveillance plan after surgery or other treatment for early, potentially curable lung cancer.
Tampa, FloridaAges 18 years+ - NCT05727228Recruiting
Risk screening for HPV after LEEP
This study looks at how to sort people into higher- or lower-risk groups after abnormal HPV testing treatment (LEEP), using repeat HPV and Pap (cytology) tests. It may help improve follow-up plans by identifying who needs closer monitoring after LEEP.
Randers, Central JutlandAges 23–64 - NCT05743673Recruiting
SHAPE test to assess pre-surgery heart and lung risk
This trial studies a quick physical test (called the SHAPE test) given before surgery to help predict your risk of complications. It may help doctors choose safer care and monitoring based on your results.
New Haven, ConnecticutAges 60 years+ - NCT05825027Recruiting
Sorting out risk in children with a recent concussion
This study looks at how to identify which children are at higher risk after a concussion and how they should be monitored. It may help doctors choose safer, more personalized follow-up care after a recent head injury.
Durham, North CarolinaAges 11–17 - NCT05889195Recruiting
Urine test to sort bladder cancer risk after blood in urine
This study tests whether a special urine testing approach can better identify and sort risk in people (especially veterans) who were referred to urology for blood in the urine. It may help doctors decide who needs more urgent follow-up and which next steps to take.
Murrieta, CaliforniaAges 18–89 - NCT05965362Recruiting
Study biomarkers to predict outcomes in heart infection
This study looks at blood and other lab test results (“biomarkers”) to better predict what may happen to people with infective endocarditis, a serious infection of the heart lining or heart valves. Your information may help doctors estimate risk and choose care more safely and effectively.
Xi'an, ShaanxiAges 18 years+ - NCT06010199Recruiting
Biomarker risk study for myocarditis patients
This study looks at certain markers in your blood to better understand the risk level of myocarditis (inflammation of the heart muscle). It may help doctors know how to best monitor and treat your condition.
Xi'an, ShaanxiAges 3–80 - NCT06100328Recruiting
Cardiac tumor study tracking health outcomes
This study looks at people with different types of heart tumors to better understand their risks and outcomes. It aims to improve how doctors predict and manage future health events.
Xi'an, ShaanxiAges 3–80 - NCT07599644Recruiting
Sepsis Risk Study in Chinese ICU Patients
This trial studies people with and without sepsis in the ICU to understand why some get very sick from infections. It aims to find better ways to predict who will have complications and guide treatment.
Shaoguan, GuangdongAges 18 years+ - NCT06352320Recruiting
Improving care for cardiomyopathy patients
This trial aims to better understand and treat cardiomyopathy by studying patients' hearts with advanced tests. It seeks to find new ways to prevent or manage the condition early.
Xi'an, ShaanxiAges 18–80 - NCT06995378Recruiting
Study on prediabetes risk tools at UCLA
This study tests a tool that uses your electronic health records to identify older adults with prediabetes. It aims to help doctors better manage risk and prevent diabetes.
Los Angeles, CaliforniaAges 65 years+ - NCT06637267Recruiting
Testing a new blood test to improve prostate cancer risk assessment
This trial is testing a new blood test (Proclarix) to see if it can better predict prostate cancer risk in men who are already scheduled for an MRI and prostate biopsy. The goal is to improve how doctors decide who needs a biopsy.
Aarau, Canton of AargauAges 45–80 - NCT06697483Recruiting
Personalized maintenance therapy for multiple myeloma after stem cell transplant
This trial tests a personalized approach to maintenance therapy for people with multiple myeloma who have already had a stem cell transplant. Your treatment plan may be adjusted based on how well your cancer responds and on certain risk factors, with the goal of keeping you in remission longer.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07013149Recruiting
Switching PAH medicines: does it change your risk?
This study looks at how changing from one PAH medicine (ambrisentan) to another (bosentan) affects your disease risk over time. It compares people who made the switch to those who stayed on ambrisentan.
São Paulo, São PauloAges 18 years+ - NCT06718075Recruiting
Comparing tools to predict stroke risk after a mini-stroke
This study looks at two ways to estimate your chance of having a stroke after a transient ischemic attack (a mini-stroke). You will be asked some questions, and your risk will be calculated using both methods. The goal is to see which tool is more accurate for patients like you.
BolognaAges 18 years+ - NCT06908785Recruiting
Blood test to predict bleeding risk after procedures in cirrhosis
This trial is testing if a special blood test called ROTEM can help doctors predict the risk of bleeding after high-risk procedures in people with cirrhosis. It aims to improve safety and guide treatment decisions.
Santander, CantabriaAges 18–65 - NCT06978998Recruiting
Retinal photos to help predict heart failure outcomes
This study tests whether a simple eye photo can help doctors better predict the course of heart failure with reduced pumping strength. If it works, this low-cost test could improve care for people with this condition.
SeoulAges 20 years+ - NCT07051083Recruiting
Bladder cancer staging trial using AI on imaging scans
This trial uses artificial intelligence to look at ultrasound and other scans to better stage bladder cancer and predict if chemotherapy before surgery might work. It may help doctors plan your treatment more precisely.
Guangzhou, GuangdongAges Any age - NCT07336394Recruiting
Study on rare heart muscle diseases using advanced MRI
This study uses a special heart MRI to better diagnose and understand rare heart muscle diseases. It may help doctors predict risks and make more accurate treatment decisions.
BeijingAges Any age - NCT07354295Recruiting
Using AI to predict treatment response in esophageal cancer
This trial uses a combination of imaging and clinical data to see if a computer model can predict how well your treatment will work. It aims to help doctors better understand your cancer risk and choose the best treatment plan for you.
Wuhan, Other (Non U.s.)Ages Any age - NCT07368205Recruiting
Risk assessment before surgery for endometrial cancer
This trial looks at better ways to predict how aggressive your endometrial cancer is before surgery, so doctors can decide if they need to check your lymph nodes. It may help tailor your treatment to avoid unnecessary procedures.
Hradec KrálovéAges 18 years+ - NCT02156401Recruiting
Study of tests and care to improve clot diagnosis
This study follows adults who may have a blood clot in the lung (pulmonary embolism) or leg (deep vein thrombosis), or who were found to have a clot by chance. It aims to improve how doctors diagnose, manage, and estimate risk, which may lead to better, more tailored care for you.
Mainz, Rhineland-PalatinateAges 18 years+
Hear when a new Risk Stratification trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for risk stratification?
- Yes. Clin2 currently lists 65 recruiting risk stratification studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a risk stratification trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a risk stratification trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.